{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:46:34Z","timestamp":1794865594280,"version":"4.9.1"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"8","funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-CIRG19may-0004"],"award-info":[{"award-number":["MOH-CIRG19may-0004"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["MOH-000541-00"],"award-info":[{"award-number":["MOH-000541-00"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Glioblastoma (GBM) is the deadliest primary brain tumor in adults, with a median survival of only 15 months and fewer than 10% of patients surviving beyond 5 years. Despite aggressive multimodal therapies, including surgical resection, radiation, and temozolomide (TMZ) chemotherapy, recurrence is almost inevitable. The mitogen-activated protein kinase interacting kinases (MNK)\u2013eIF4E axis plays a significant role in cancer cell survival, and MNK1 and MNK2 are upregulated in gliomas. In this study, we discovered that elevated MNK1\/2 expression correlates with poor prognosis and aggressive GBM phenotypes. The development of ETC-501, a selective brain-penetrant MNK inhibitor, enabled modulation of key oncogenic pathways, including MYC signaling, DNA replication, cell-cycle regulation, and inflammation. ETC-501 effectively inhibited GBM proliferation, impaired DNA damage repair, delayed cell-cycle progression, and suppressed ribosome biogenesis. Notably, in combination with TMZ, ETC-501 not only enhanced senescence but also attenuated the senescence-associated secretory phenotype in GBM cells. The augmented senescence increased the vulnerability of GBM cells to the senolytic agent navitoclax, facilitating the targeted elimination of residual senescent cells. These findings underscore the therapeutic potential of MNK inhibition in GBM, offering a promising strategy to advance GBM treatment paradigms and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Targeting MNK1\/2 enhances the efficacy of cancer therapy and promotes senescence to prime cancer cells for elimination by senolytic drugs, providing a treatment strategy to manage tumor recurrence in glioblastoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-24-4388","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:56:38Z","timestamp":1769118998000},"page":"2060-2077","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4328-8072","authenticated-orcid":false,"given":"Giselle Sek Suan","family":"Nah","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02j1m6098","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke-NUS Medical School 1 Cancer and Stem Cell Biology Programme, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1087-7151","authenticated-orcid":false,"given":"Yuk Kien","family":"Chong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03d58dr58","id-type":"ROR","asserted-by":"publisher"}],"name":"National Neuroscience Institute 2 Department of Research, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2805-4712","authenticated-orcid":false,"given":"Fatin Nasha","family":"Sulaimi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02j1m6098","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke-NUS Medical School 1 Cancer and Stem Cell Biology Programme, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-2746","authenticated-orcid":false,"given":"Kian Leong","family":"Lee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02j1m6098","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke-NUS Medical School 1 Cancer and Stem Cell Biology Programme, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-4577","authenticated-orcid":false,"given":"See Wee","family":"Lim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03d58dr58","id-type":"ROR","asserted-by":"publisher"}],"name":"National Neuroscience Institute 2 Department of Research, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8988-7255","authenticated-orcid":false,"given":"Qing You","family":"Pang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03d58dr58","id-type":"ROR","asserted-by":"publisher"}],"name":"National Neuroscience Institute 2 Department of Research, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5346-2589","authenticated-orcid":false,"given":"Mengge","family":"Yu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02j1m6098","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke-NUS Medical School 1 Cancer and Stem Cell Biology Programme, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9582-9299","authenticated-orcid":false,"given":"Zhen Wei","family":"Neo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036j6sg82","id-type":"ROR","asserted-by":"publisher"}],"name":"Singapore General Hospital 3 Department of Anatomical Pathology, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-1791","authenticated-orcid":false,"given":"Jabed","family":"Iqbal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036j6sg82","id-type":"ROR","asserted-by":"publisher"}],"name":"Singapore General Hospital 3 Department of Anatomical Pathology, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3291-0215","authenticated-orcid":false,"given":"Kassoum","family":"Nacro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kx02w94","id-type":"ROR","asserted-by":"publisher"}],"name":"Experimental Drug Development Centre 4 , , Singapore, Singapore."},{"id":[{"id":"https:\/\/ror.org\/036wvzt09","id-type":"ROR","asserted-by":"publisher"}],"name":"A*STAR 4 , , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-1977","authenticated-orcid":false,"given":"Jeffrey","family":"Hill","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kx02w94","id-type":"ROR","asserted-by":"publisher"}],"name":"Experimental Drug Development Centre 4 , , Singapore, Singapore."},{"id":[{"id":"https:\/\/ror.org\/036wvzt09","id-type":"ROR","asserted-by":"publisher"}],"name":"A*STAR 4 , , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-5808","authenticated-orcid":false,"given":"Alex","family":"Matter","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kx02w94","id-type":"ROR","asserted-by":"publisher"}],"name":"Experimental Drug Development Centre 4 , , Singapore, Singapore."},{"id":[{"id":"https:\/\/ror.org\/036wvzt09","id-type":"ROR","asserted-by":"publisher"}],"name":"A*STAR 4 , , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1155-8216","authenticated-orcid":false,"given":"Henry","family":"Yang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01tgyzw49","id-type":"ROR","asserted-by":"publisher"}],"name":"National University of Singapore 5 Cancer Science Institute, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7252-5146","authenticated-orcid":false,"given":"Beng Ti","family":"Ang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03d58dr58","id-type":"ROR","asserted-by":"publisher"}],"name":"National Neuroscience Institute 2 Department of Research, , Singapore, Singapore."},{"id":[{"id":"https:\/\/ror.org\/02j1m6098","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke-NUS Medical School 6 SingHealth Duke-NUS Neuroscience Academic Clinical Programme, , Singapore, Singapore."},{"id":[{"id":"https:\/\/ror.org\/03d58dr58","id-type":"ROR","asserted-by":"publisher"}],"name":"National Neuroscience Institute 7 Department of Neurosurgery, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1835-5083","authenticated-orcid":false,"given":"Carol","family":"Tang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03d58dr58","id-type":"ROR","asserted-by":"publisher"}],"name":"National Neuroscience Institute 2 Department of Research, , Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-3483","authenticated-orcid":false,"given":"S. Tiong","family":"Ong","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02j1m6098","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke-NUS Medical School 1 Cancer and Stem Cell Biology Programme, , Singapore, Singapore."},{"id":[{"id":"https:\/\/ror.org\/036j6sg82","id-type":"ROR","asserted-by":"publisher"}],"name":"Singapore General Hospital 8 Department of Hematology, , Singapore, Singapore."},{"name":"9Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"Suppl 2","key":"2026041503145380800_bib1","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026041503145380800_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI89587","article-title":"Overcoming therapeutic resistance in glioblastoma: the way forward","volume":"127","author":"Osuka","year":"2017","journal-title":"J Clin Invest"},{"key":"2026041503145380800_bib3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"2026041503145380800_bib4","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.3390\/cancers15133458","article-title":"Emerging role of glioma stem cells in mechanisms of therapy resistance","volume":"15","author":"Eckerdt","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026041503145380800_bib5","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","article-title":"Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma","volume":"28","author":"Qazi","year":"2017","journal-title":"Ann Oncol"},{"key":"2026041503145380800_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/neuonc\/nov164","article-title":"Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma","volume":"18","author":"Oberoi","year":"2016","journal-title":"Neuro Oncol"},{"key":"2026041503145380800_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2015.05.049","article-title":"Differential requirements for eIF4E dose in normal development and cancer","volume":"162","author":"Truitt","year":"2015","journal-title":"Cell"},{"key":"2026041503145380800_bib8","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1128\/MCB.24.15.6539-6549.2004","article-title":"Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development","volume":"24","author":"Ueda","year":"2004","journal-title":"Mol Cell Biol"},{"key":"2026041503145380800_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/BST20150126","article-title":"Signalling to eIF4E in cancer","volume":"43","author":"Siddiqui","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"2026041503145380800_bib10","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1073\/pnas.1008136107","article-title":"Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development","volume":"107","author":"Ueda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041503145380800_bib11","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1073\/pnas.1005320107","article-title":"eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression","volume":"107","author":"Furic","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041503145380800_bib12","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1101\/gad.1604407","article-title":"Dissecting eIF4E action in tumorigenesis","volume":"21","author":"Wendel","year":"2007","journal-title":"Genes Dev"},{"key":"2026041503145380800_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4161\/cbt.10.7.12965","article-title":"The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival","volume":"10","author":"Wheater","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"2026041503145380800_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/onc.2012.43","article-title":"MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells","volume":"32","author":"Shi","year":"2013","journal-title":"Oncogene"},{"key":"2026041503145380800_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1515\/bmc-2011-1057","article-title":"Mnk kinases in cytokine signaling and regulation of cytokine responses","volume":"3","author":"Joshi","year":"2012","journal-title":"Biomol Concepts"},{"key":"2026041503145380800_bib16","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cellsig.2016.06.005","article-title":"Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy","volume":"28","author":"Grzmil","year":"2016","journal-title":"Cell Signal"},{"key":"2026041503145380800_bib17","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/0008-5472.CAN-10-3112","article-title":"MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-beta signaling pathway in human glioblastoma","volume":"71","author":"Grzmil","year":"2011","journal-title":"Cancer Res"},{"key":"2026041503145380800_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1172\/JCI70198","article-title":"MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas","volume":"124","author":"Grzmil","year":"2014","journal-title":"J Clin Invest"},{"key":"2026041503145380800_bib19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1158\/1541-7786.MCR-16-0172","article-title":"MNK inhibition disrupts mesenchymal glioma stem cells and prolongs survival in a mouse model of glioblastoma","volume":"14","author":"Bell","year":"2016","journal-title":"Mol Cancer Res"},{"key":"2026041503145380800_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1541-7786.MCR-17-0397","article-title":"Differential response of glioma stem cells to arsenic trioxide therapy is regulated by MNK1 and mRNA translation","volume":"16","author":"Bell","year":"2018","journal-title":"Mol Cancer Res"},{"key":"2026041503145380800_bib21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/cancers12040822","article-title":"Therapy-induced senescence: an \u201cold\u201d friend becomes the enemy","volume":"12","author":"Saleh","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026041503145380800_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Coppe","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"2026041503145380800_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41698-023-00476-8","article-title":"An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence","volume":"7","author":"Riviere-Cazaux","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"2026041503145380800_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2016.01.071","article-title":"Senescence from glioma stem cell differentiation promotes tumor growth","volume":"470","author":"Ouchi","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"2026041503145380800_bib25","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1158\/0008-5472.CAN-12-4124","article-title":"GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-alpha","volume":"73","author":"Kohanbash","year":"2013","journal-title":"Cancer Res"},{"key":"2026041503145380800_bib26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1541-7786.MCR-21-0029","article-title":"Selective vulnerability of senescent glioblastoma cells to BCL-XL inhibition","volume":"20","author":"Rahman","year":"2022","journal-title":"Mol Cancer Res"},{"key":"2026041503145380800_bib27","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1158\/0008-5472.CAN-21-0752","article-title":"Elimination of radiation-induced senescence in the brain tumor microenvironment attenuates glioblastoma recurrence","volume":"81","author":"Fletcher-Sananikone","year":"2021","journal-title":"Cancer Res"},{"key":"2026041503145380800_bib28","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/15548627.2016.1178446","article-title":"A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: hypoxia-Induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway","volume":"12","author":"Xue","year":"2016","journal-title":"Autophagy"},{"key":"2026041503145380800_bib29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1523\/JNEUROSCI.16-03-01091.1996","article-title":"Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor","volume":"16","author":"Gritti","year":"1996","journal-title":"J Neurosci"},{"key":"2026041503145380800_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-59745-361-5_3","article-title":"Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay","volume":"371","author":"Itahana","year":"2007","journal-title":"Methods Mol Biol"},{"key":"2026041503145380800_bib31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"2026041503145380800_bib32","doi-asserted-by":"crossref","first-page":"103009","DOI":"10.1016\/j.xpro.2024.103009","article-title":"Protocol to detect senescence-associated beta-galactosidase and immunoperoxidase activity in fresh-frozen murine tissues","volume":"5","author":"Idelfonso-Garc\u00eda","year":"2024","journal-title":"STAR Protoc"},{"key":"2026041503145380800_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"key":"2026041503145380800_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2026041503145380800_bib35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"2026041503145380800_bib36","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041503145380800_bib37","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026041503145380800_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"2026041503145380800_bib39","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/neuonc\/noae028","article-title":"Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide","volume":"26","author":"Cheng","year":"2024","journal-title":"Neuro Oncol"},{"key":"2026041503145380800_bib40","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/acs.jmedchem.7b01795","article-title":"Structure-based design of pyridone-aminal eFT508 targeting dysregulated translation by selective mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1\/2) inhibition","volume":"61","author":"Reich","year":"2018","journal-title":"J Med Chem"},{"key":"2026041503145380800_bib41","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1016\/j.wneu.2018.09.177","article-title":"Significance and prognostic value of the coagulation profile in patients with glioblastoma: implications for personalized therapy","volume":"121","author":"Navone","year":"2019","journal-title":"World Neurosurg"},{"key":"2026041503145380800_bib42","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/cancers14092233","article-title":"Senescence is the main trait induced by temozolomide in glioblastoma cells","volume":"14","author":"Beltzig","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026041503145380800_bib43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s42003-024-06263-w","article-title":"Replication stress as a driver of cellular senescence and aging","volume":"7","author":"Herr","year":"2024","journal-title":"Commun Biol"},{"key":"2026041503145380800_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1158\/0008-5472.CAN-18-1733","article-title":"Temozolomide induces senescence and repression of DNA repair pathways in glioblastoma cells via activation of ATR-CHK1, p21, and NF-kappaB","volume":"79","author":"Aasland","year":"2019","journal-title":"Cancer Res"},{"key":"2026041503145380800_bib45","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/stem.188","article-title":"Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth","volume":"27","author":"Wang","year":"2009","journal-title":"Stem Cells"},{"key":"2026041503145380800_bib46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bph.12008","article-title":"Interleukins in glioblastoma pathophysiology: implications for therapy","volume":"168","author":"Yeung","year":"2013","journal-title":"Br J Pharmacol"},{"key":"2026041503145380800_bib47","doi-asserted-by":"crossref","first-page":"e2304609","DOI":"10.1002\/advs.202304609","article-title":"Radiotherapy-induced astrocyte senescence promotes an immunosuppressive microenvironment in glioblastoma to facilitate tumor regrowth","volume":"11","author":"Ji","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"2026041503145380800_bib48","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/0008-5472.CAN-16-2310","article-title":"Cellular and molecular identity of tumor-associated macrophages in glioblastoma","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res"},{"key":"2026041503145380800_bib49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/ijms19020436","article-title":"When immune cells turn bad-tumor-associated microglia\/macrophages in glioma","volume":"19","author":"Roesch","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026041503145380800_bib50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jgo.2014.08.003","article-title":"Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas","volume":"5","author":"Coppola","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"2026041503145380800_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.celrep.2017.09.085","article-title":"High-throughput functional genetic and compound screens identify targets for senescence induction in cancer","volume":"21","author":"Wang","year":"2017","journal-title":"Cell Rep"},{"key":"2026041503145380800_bib52","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.3390\/ijms21114037","article-title":"Myc as a regulator of ribosome biogenesis and cell competition: a link to cancer","volume":"21","author":"Destefanis","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026041503145380800_bib53","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/neuonc\/noac286","article-title":"Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth","volume":"25","author":"Zisi","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026041503145380800_bib54","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3390\/cells11142142","article-title":"Ribosomes and ribosomal proteins promote plasticity and stemness induction in glioma cells via reprogramming","volume":"11","author":"Hide","year":"2022","journal-title":"Cells"},{"key":"2026041503145380800_bib55","doi-asserted-by":"crossref","first-page":"751792","DOI":"10.3389\/fonc.2021.751792","article-title":"Suppression of ribosome biogenesis by targeting WD repeat domain 12 (WDR12) inhibits glioma stem-like cell growth","volume":"11","author":"Mi","year":"2021","journal-title":"Front Oncol"},{"key":"2026041503145380800_bib56","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1101\/gad.17276711","article-title":"Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity","volume":"25","author":"Chien","year":"2011","journal-title":"Genes Dev"},{"key":"2026041503145380800_bib57","first-page":"816.e1","article-title":"SnapShot: cellular senescence pathways","volume":"170","author":"Martinez-Zamudio","year":"2017","journal-title":"Cell"},{"key":"2026041503145380800_bib58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11357-020-00183-3","article-title":"Regulation of senescence traits by MAPKs","volume":"42","author":"Anerillas","year":"2020","journal-title":"Geroscience"},{"key":"2026041503145380800_bib59","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ccell.2023.06.007","article-title":"Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling","volume":"41","author":"Jeon","year":"2023","journal-title":"Cancer Cell"},{"key":"2026041503145380800_bib60","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s12864-023-09674-x","article-title":"Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme","volume":"24","author":"Deng","year":"2023","journal-title":"BMC Genomics"},{"key":"2026041503145380800_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","article-title":"Macrophages and microglia: the cerberus of glioblastoma","volume":"9","author":"Buonfiglioli","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"2026041503145380800_bib62","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1158\/1078-0432.CCR-06-2772","article-title":"Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2","volume":"13","author":"Carlson","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026041503145380800_bib63","doi-asserted-by":"crossref","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","article-title":"MCP-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"2026041503145380800_bib64","doi-asserted-by":"crossref","first-page":"e36483","DOI":"10.1016\/j.heliyon.2024.e36483","article-title":"Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates","volume":"10","author":"Greenberg","year":"2024","journal-title":"Heliyon"},{"key":"2026041503145380800_bib65","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity","volume":"11","author":"Wilson","year":"2010","journal-title":"Lancet Oncol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-4388\/3727849\/can-24-4388.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/8\/2060\/3764913\/can-24-4388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/8\/2060\/3764913\/can-24-4388.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:15:13Z","timestamp":1776237313000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/8\/2060\/782634\/ETC-501-Is-a-Brain-Penetrant-MNK-Inhibitor-That"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,1,22]]},"published-print":{"date-parts":[[2026,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-4388","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.32714901","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32714889","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32714895","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32714883","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32714886","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32714880","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32714892","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8542725","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}